Distribution September 26, 2018 Frequently Asked Questions – 340B Program 4 Minute Read The 340B program is subject to increasing scrutiny as pharmaceutical manufacturers search for solutions to identify and act on non-compliance such as diversion and duplicate discounts. This post is...
Channel August 20, 2018 Opioid Crisis Exposes Vulnerabilities in Suspicious Order Monitoring 4 Minute Read The American opioid crisis exposed gaps in the reporting systems designed to flag suspicious orders of pharmaceutical products classified as controlled substances. Pharmaceutical manufacturers are now facing increased scrutiny...
